GSA Capital Partners’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
NTCM
GSA Capital Partners's IRMD Position: Q2 2026 in Review
GSA Capital Partners reduced its iRadimed (IRMD) stake by 2.9% in Q2 2026, selling an estimated $19.2K and leaving 7,063 shares worth $675K. The position accounts for 0.04% of the portfolio, ranked #788.
GSA Capital Partners first reported a position in IRMD in Q3 2015 and has held it in 18 quarters since. The position peaked at $1.41M in Q4 2015. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- GSA Capital Partners held 7,063 shares of iRadimed worth $675K as of Q2 2026.
- GSA Capital Partners sold 211 iRadimed shares in Q2 2026, an estimated $19.2K.
- iRadimed made up 0.04% of GSA Capital Partners's portfolio in Q2 2026, its #788 holding.
- GSA Capital Partners first reported a position in iRadimed in Q3 2015 and has held it in 18 quarters since.
- GSA Capital Partners's iRadimed position peaked at $1.41M in Q4 2015.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.